These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9727665)

  • 1. Electrical proarrhythmia: induction of inappropriate atrial therapies due to far-field R wave oversensing in a new dual chamber defibrillator.
    Wolpert C; Jung W; Scholl C; Spehl S; Cyran J; Lüderitz B
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8):859-63. PubMed ID: 9727665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator.
    Swerdlow CD; Chen PS; Kass RM; Allard JR; Peter CT
    J Am Coll Cardiol; 1994 May; 23(6):1342-55. PubMed ID: 8176092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of bradycardia pacing and detection of ventricular fibrillation due to far-field atrial sensing in a triple chamber implantable cardioverter defibrillator.
    Vollmann D; Lüthje L; Görtler G; Unterberg C
    Pacing Clin Electrophysiol; 2002 Oct; 25(10):1513-6. PubMed ID: 12418750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of appropriate inappropriate device therapy: hyperkalemia-induced ventricular oversensing.
    Oudit GY; Cameron D; Harris L
    Can J Cardiol; 2008 Mar; 24(3):e16-8. PubMed ID: 18340383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Far-field R wave oversensing in a dual chamber arrhythmia management device: predisposing factors and practical implications.
    Weretka S; Becker R; Hilbel T; Karle C; Osswald BR; Kuebler W; Schoels W
    Pacing Clin Electrophysiol; 2001 Aug; 24(8 Pt 1):1240-6. PubMed ID: 11523610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
    Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter defibrillator proarrhythmia due to an interaction with "noncompetitive atrial pacing": an algorithm to prevent atrial arrhythmias.
    Cron TA; Schaer B; Osswald S
    Pacing Clin Electrophysiol; 2002 Nov; 25(11):1656-9. PubMed ID: 12494629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: inappropriate discharge of an implantable cardioverter-defibrillator caused by the combined count criterion.
    Wolpert C; Jung W; Spehl S; Korte T; Lüderitz B
    J Interv Card Electrophysiol; 1998 Mar; 2(1):53-6. PubMed ID: 9869997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
    Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator.
    Gillis AM; Unterberg-Buchwald C; Schmidinger H; Massimo S; Wolfe K; Kavaney DJ; Otterness MF; Hohnloser SH;
    J Am Coll Cardiol; 2002 Nov; 40(9):1653-9. PubMed ID: 12427419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators.
    Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH
    Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate shock delivery due to ventricular double detection with a biventricular pacing implantable cardioverter defibrillator.
    Schreieck J; Zrenner B; Kolb C; Ndrepepa G; Schmitt C
    Pacing Clin Electrophysiol; 2001 Jul; 24(7):1154-7. PubMed ID: 11475833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate discharges by fourth generation implantable cardioverter defibrillators in patients with ventricular arrhythmias.
    Washizuka T; Chinushi M; Tagawa M; Kasai H; Watanabe H; Hosaka Y; Yamashita F; Furushima H; Abe A; Watanabe H; Hayashi J; Aizawa Y
    Jpn Circ J; 2001 Nov; 65(11):927-30. PubMed ID: 11716240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillators.
    Weber M; Böcker D; Bänsch D; Brunn J; Castrucci M; Gradaus R; Breithardt G; Block M
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):145-53. PubMed ID: 10090217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICD proarrhythmia as a consequence of an interaction with an algorithm to prevent atrial arrhythmias.
    Martínez-Sánchez J; García-Alberola A; Sánchez-Muñoz JJ; Peñafiel-Verdú P; Giner-Caro JA; Valdés-Chávarri M
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1096-8. PubMed ID: 19659632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new dual-chamber defibrillation system: duration, frequency and circadian variation of recurrent supraventricular tachyarrhythmias].
    Wolpert C; Jung W; Herwig S; Schimpf R; Lüderitz B
    Herz; 2001 Feb; 26(1):55-63. PubMed ID: 11258110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-wave oversensing in implantable cardiac defibrillators is due to technical failure of device sensing.
    Gilliam FR
    J Cardiovasc Electrophysiol; 2006 May; 17(5):553-6. PubMed ID: 16684033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of bradycardia pacing caused by far-field atrial sensing in a third-generation cardioverter defibrillator with an automatic gain feature.
    Curwin JH; Roelke M; Ruskin JN
    Pacing Clin Electrophysiol; 1996 Jan; 19(1):124-6. PubMed ID: 8848369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.